Female BRCA2 carriers face a 55% lifetime risk of breast cancer and 10–15% of ovarian cancer, while male carriers have a 7.1% risk by age 70 and 8.4% by age 80 [30–32]. This evidence concerns the gene BRCA2 and breast cancer.